SERPINB2 anticorps (Middle Region)
-
- Antigène Voir toutes SERPINB2 Anticorps
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Rat, Souris, Lapin, Boeuf (Vache), Cobaye, Cheval, Chien, Mouton
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SERPINB2 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- GKIPNLLPEG SVDGDTRMVL VNAVYFKGKW KTPFEKKLNG LYPFRVNSAQ
- Homologie
- Cow: 86%, Dog: 100%, Guinea Pig: 92%, Horse: 93%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 85%, Sheep: 86%
- Attributs du produit
- This is a rabbit polyclonal antibody against SERPINB2. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human SERPINB2
- Top Product
- Discover our top product SERPINB2 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 415 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma." dans: Molecular cancer therapeutics, Vol. 6, Issue 1, pp. 203-12, (2007) (PubMed).
: "
-
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma." dans: Molecular cancer therapeutics, Vol. 6, Issue 1, pp. 203-12, (2007) (PubMed).
-
- Antigène
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
- Autre désignation
- SERPINB2 (SERPINB2 Produits)
- Synonymes
- anticorps HsT1201, anticorps PAI, anticorps PAI-2, anticorps PAI2, anticorps PLANH2, anticorps SERPINB2, anticorps Planh2, anticorps ovalbumin, anticorps Pai2a, anticorps serpin family B member 2, anticorps serpin peptidase inhibitor, clade B (ovalbumin), member 2, anticorps serine (or cysteine) peptidase inhibitor, clade B, member 2, anticorps SERPINB2, anticorps Serpinb2
- Classe de substances
- Amino Acid
- Sujet
-
SERPINB2 inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1.
Alias Symbols: HsT1201, PAI, PAI-2, PAI2, PLANH2
Protein Interaction Partner: UBC, APP, PRPF8, PSMB1, RBL2, RB1, IRF3, PLAU, SERPINB2,
Protein Size: 415 - Poids moléculaire
- 44 kDa
- ID gène
- 5055
- NCBI Accession
- NM_002575, NP_002566
- UniProt
- P05120
- Pathways
- Autophagy
-